FRONTONI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 1.937
EU - Europa 629
AS - Asia 343
SA - Sud America 17
AF - Africa 5
OC - Oceania 5
Totale 2.936
Nazione #
US - Stati Uniti d'America 1.924
IT - Italia 195
SG - Singapore 150
IN - India 108
UA - Ucraina 101
SE - Svezia 88
CN - Cina 69
DE - Germania 65
FI - Finlandia 58
RU - Federazione Russa 46
AT - Austria 23
CA - Canada 12
GB - Regno Unito 12
AR - Argentina 10
BG - Bulgaria 8
IE - Irlanda 7
BR - Brasile 6
BE - Belgio 5
ID - Indonesia 5
NL - Olanda 5
IQ - Iraq 4
RO - Romania 4
TG - Togo 4
AU - Australia 3
CH - Svizzera 2
FR - Francia 2
HK - Hong Kong 2
KR - Corea 2
LT - Lituania 2
NZ - Nuova Zelanda 2
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
GR - Grecia 1
IR - Iran 1
LV - Lettonia 1
MK - Macedonia 1
MX - Messico 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 2.936
Città #
Fairfield 327
Woodbridge 166
Chandler 155
Ashburn 154
Houston 127
Seattle 106
Cambridge 89
Wilmington 83
Ann Arbor 82
Singapore 77
Rome 67
Princeton 53
Plano 46
Jacksonville 42
Dearborn 35
Boston 33
Beijing 32
San Paolo di Civitate 31
Lawrence 27
Santa Clara 25
Des Moines 24
Grafing 20
Millbury 17
Vienna 17
Helsinki 15
San Diego 15
Andover 11
Munich 11
New York 11
Moscow 10
Norwalk 10
Federal 9
Yubileyny 9
Sofia 8
Toronto 8
Boardman 7
Dublin 7
Falkenstein 7
Falls Church 7
Milan 6
Brussels 5
Fasano 5
Hefei 5
Jakarta 5
Mannheim 5
Fremont 4
Lomé 4
Los Angeles 4
Nanjing 4
Nuremberg 4
Venezia 4
Amsterdam 3
Baghdad 3
Chapel Hill 3
Dallas 3
Genzano 3
Lidköping 3
London 3
Ottawa 3
Bari 2
Bern 2
Bühl 2
Castelnuovo del Garda 2
Conegliano 2
Foggia 2
Frankfurt am Main 2
Hong Kong 2
Lappeenranta 2
Laurel 2
Modugno 2
Naples 2
Napoli 2
Padova 2
Philadelphia 2
Porto Recanati 2
San Mateo 2
Simi Valley 2
Tower Hamlets 2
Venice 2
Algiers 1
Atlanta 1
Auckland 1
Basra 1
Belo Horizonte 1
Bolzano Vicentino 1
Bonndorf 1
Bratislava 1
Bucharest 1
Buffalo 1
Camaquã 1
Catanzaro 1
Cernobbio 1
Changchun 1
Collegno 1
Coominya 1
Copenhagen 1
Council Bluffs 1
Cutrofiano 1
Edinburgh 1
Elk Grove 1
Totale 2.120
Nome #
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis 119
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS 110
Ballismo, atetosi e discinesie parossistiche 107
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 96
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study 90
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 88
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis 82
MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis. 81
Ultrasonographic evaluation of cerebral arterial and venous haemodynamics in multiple sclerosis: a case-control study. 80
Parkinson's disease related pain: a review of recent findings. 77
Cost minimization analysis of BoNT-As in the treatment of upper limb spasticity and cervical dystonia 77
Power spectrum analysis contribution to the detection of cardiovascular dysautonomia in multiple sclerosis. 76
Can the Expanded Disability Status Scale be assessed by telephone? 76
Reversed laterality of cerebral functions in a non-right-hander: neuropsychological and spect findings in a case of 'atypical' dominance. 72
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 72
Photophobia in multiple sclerosis 71
Early fibrinolysis and brain protection: design of a four-arm clinical trial in brain infarction. 69
Fatigue in Parkinson's disease: Motor or non-motor symptom? 68
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus 68
Effect of stress on cardiovascular regulation in neurological diseases with dysautonomia. 65
Thrombolysis in acute ischemic stroke 64
Cardiac autonomic dysfunction in relapsing-remitting multiple sclerosis during a stable phase 63
MAGNETIC RESONANCE IMAGING OUTCOME OF NEW ENHANCING LESIONS IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS TREATED WITH INTERFERON-B1A 62
Invasive treatment of acute stroke. 59
Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers 59
Power spectrum analysis contribution to the detection of cardiovascular dysautonomia in multiple sclerosis. 58
MRI in multiple sclerosis during the menstrual cycle: Relationship with sex hormone patterns 58
AUTONOMIC DYSFUNCTION IN MULTIPLE SCLEROSIS 55
Determinants of Gd-enhanced MRI response to IFN-beta-I a treatment in relapsing-remitting multiple sclerosis 55
Update on calcium antagonists in cerebrovascular diseases. 55
Pharmacological approach to acute ischemic stroke 53
INVASIVE TREATMENT OF ACUTE STROKE 53
Cardiac autonomic dysfunction in patients with alzheimer's disease: possible pathogenetic mechanisms. 51
Autonomic dysfunction in MS 50
Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study 50
Treatment of Acute Ischemic Stroke 50
Malattie cerebrovascolari. 49
No increase of serum autoantibodies during therapy with recombinant human interferon-beta1a in relapsing-remitting multiple sclerosis. 47
POWER SPECTRUM ANALYSIS CONTRIBUTION TO THE DETECTION OF CARDIOVASCULAR DYSAUTONOMIA IN MULTIPLE SCLEROSIS 46
Malattie cerebrovascolari 45
Does hyperglicemia play a role on the outcome of acute ischemic stroke patients? 44
Correlations between sexual hormones and disease activity on MRI in multiple sclerosis 37
Chronic Cerebro-Spinal Venous Insufficiency is not significantly associated to Relapsing-Remitting Multiple Sclerosis. 37
Magnetic resonance disease activity in multiple sclerosis (MS): correlation with menstrual cycle phase and hormonal parameters 35
NO INCREASE OF SERUM ANTIBODIES DURING THERAPY WITH RECOMBINANT HUMAN INTERFERON-B1A IN RELAPSING-REMITTING MULTIPLE SCLEROSIS 35
Controlled clinical trials in stroke. 34
Malignant gastric carcinoid and paraneoplastic cerebellar degeneration 21
What are we learning form clinical trials in acute cerebral ischemia? 20
Evaluation of medical treatment in acute ischemic stroke 18
Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon beta1a. 16
Totale 3.023
Categoria #
all - tutte 8.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.756


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020179 0 0 0 0 0 0 0 0 70 61 34 14
2020/2021251 29 23 10 18 4 24 3 23 21 69 20 7
2021/2022506 3 20 36 25 72 14 18 44 43 33 86 112
2022/2023539 98 106 42 40 58 68 5 34 56 5 16 11
2023/2024224 11 40 3 18 15 25 1 29 0 26 32 24
2024/2025282 19 29 20 31 27 39 46 50 21 0 0 0
Totale 3.023